Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI

Abstract Background Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This may be explained by overlapping clinical symptoms, e.g. Parkinsonism. Wh...

Full description

Bibliographic Details
Main Authors: Sebastian Johannes Müller, Eya Khadhraoui, Niels Hansen, Ala Jamous, Philip Langer, Jens Wiltfang, Christian Heiner Riedel, Caroline Bouter, Christoph van Riesen, Fabian Maass, Michael Bartl, Claudia Lange, Marielle Ernst
Format: Article
Language:English
Published: BMC 2023-03-01
Series:BMC Neurology
Subjects:
Online Access:https://doi.org/10.1186/s12883-023-03151-4
_version_ 1797864331558256640
author Sebastian Johannes Müller
Eya Khadhraoui
Niels Hansen
Ala Jamous
Philip Langer
Jens Wiltfang
Christian Heiner Riedel
Caroline Bouter
Christoph van Riesen
Fabian Maass
Michael Bartl
Claudia Lange
Marielle Ernst
author_facet Sebastian Johannes Müller
Eya Khadhraoui
Niels Hansen
Ala Jamous
Philip Langer
Jens Wiltfang
Christian Heiner Riedel
Caroline Bouter
Christoph van Riesen
Fabian Maass
Michael Bartl
Claudia Lange
Marielle Ernst
author_sort Sebastian Johannes Müller
collection DOAJ
description Abstract Background Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This may be explained by overlapping clinical symptoms, e.g. Parkinsonism. While current MRI research focuses primarily on atrophy patterns of the frontal and temporal lobes, we focus on brainstem characteristics of DLB. In particular, we focused on brainstem atrophy patterns distinguishing DLB from Progressive Supranuclear Palsy (PSP) and PD based as the most common differential diagnoses. Methods We identified patients diagnosed with DLB, PD, PSP, and a control group (CTRL) in our psychiatric and neurological archives. All patients with competing diagnoses and without a high-quality T1 MPRAGE 3D dataset were excluded. We assessed atrophy patterns in all patients (1) manually and (2) using FastSurfer’s segmentation algorithm in combination with FreeSurfer’s brainstem volumetric calculations. We compared classical measurement methods and ratios with automated volumetric approaches. Results One hundred two patients were enrolled and evaluated in this study. Patients with DLB (n = 37) showed on average less atrophy of the brainstem than patients with PSP (n = 21), but a significantly more pronounced atrophy than patients with PD (n = 36) and the control group (CTRL, n = 8). The mean measured sagittal diameters of the midbrain were 8.17 ± 1.06 mm (mean ± standard deviation) for PSP, 9.45 ± 0.95 mm for DLB, 10.37 ± 0.99 mm for PD and 10.74 ± 0.70 for CTRL. The mean measured areas of the midbrain were 81 ± 18 mm2 for PSP, 105 ± 17 mm2 for DLB, 130 ± 26 mm2 for PD and 135 ± 23 mm2 for CTRL. The mean segmented volumes of the midbrain were 5595 ± 680 mm3 for PSP, 6051 ± 566 mm3 for DLB, 6646 ± 802 mm3 for PD and 6882 ± 844 mm3 for CTRL. The calculated midbrain pons ratios did not show superiority over the absolute measurements of the midbrain for distinguishing PSP from DLB. Because of the relatively uniform atrophy throughout the brainstem, the ratios were not suitable for distinguishing DLB from PD. Conclusions DLB patients exhibit homogenous atrophy of the brainstem and can be distinguished from patients with PSP and PD by both manual measurement methods and automated volume segmentation using absolute values or ratios.
first_indexed 2024-04-09T22:51:08Z
format Article
id doaj.art-12afb2514bb849bcbca9e616bd0ff8f2
institution Directory Open Access Journal
issn 1471-2377
language English
last_indexed 2024-04-09T22:51:08Z
publishDate 2023-03-01
publisher BMC
record_format Article
series BMC Neurology
spelling doaj.art-12afb2514bb849bcbca9e616bd0ff8f22023-03-22T11:38:31ZengBMCBMC Neurology1471-23772023-03-012311910.1186/s12883-023-03151-4Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRISebastian Johannes Müller0Eya Khadhraoui1Niels Hansen2Ala Jamous3Philip Langer4Jens Wiltfang5Christian Heiner Riedel6Caroline Bouter7Christoph van Riesen8Fabian Maass9Michael Bartl10Claudia Lange11Marielle Ernst12Institute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University GöttingenInstitute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University GöttingenDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August-UniversityInstitute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University GöttingenInstitute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University GöttingenDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August-UniversityInstitute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University GöttingenDepartment of Nuclear Medicine, University Medical Center Göttingen (UMG), Georg-August-UniversityGerman Center for Neurodegenerative Diseases (DZNE)Department of Neurology, University Medical Center Göttingen (UMG), Georg-August-UniversityDepartment of Neurology, University Medical Center Göttingen (UMG), Georg-August-UniversityDepartment of Psychiatry and Psychotherapy, University Medical Center Göttingen (UMG), Georg-August-UniversityInstitute of Diagnostic and Interventional Neuroradiology, University Medical Center Göttingen (UMG), Georg-August-University GöttingenAbstract Background Although Dementia with Lewy bodies (DLB) is the second most common form of dementia in elderly patients, it remains underdiagnosed compared with Alzheimer's (AD) and Parkinson's diseases (PD). This may be explained by overlapping clinical symptoms, e.g. Parkinsonism. While current MRI research focuses primarily on atrophy patterns of the frontal and temporal lobes, we focus on brainstem characteristics of DLB. In particular, we focused on brainstem atrophy patterns distinguishing DLB from Progressive Supranuclear Palsy (PSP) and PD based as the most common differential diagnoses. Methods We identified patients diagnosed with DLB, PD, PSP, and a control group (CTRL) in our psychiatric and neurological archives. All patients with competing diagnoses and without a high-quality T1 MPRAGE 3D dataset were excluded. We assessed atrophy patterns in all patients (1) manually and (2) using FastSurfer’s segmentation algorithm in combination with FreeSurfer’s brainstem volumetric calculations. We compared classical measurement methods and ratios with automated volumetric approaches. Results One hundred two patients were enrolled and evaluated in this study. Patients with DLB (n = 37) showed on average less atrophy of the brainstem than patients with PSP (n = 21), but a significantly more pronounced atrophy than patients with PD (n = 36) and the control group (CTRL, n = 8). The mean measured sagittal diameters of the midbrain were 8.17 ± 1.06 mm (mean ± standard deviation) for PSP, 9.45 ± 0.95 mm for DLB, 10.37 ± 0.99 mm for PD and 10.74 ± 0.70 for CTRL. The mean measured areas of the midbrain were 81 ± 18 mm2 for PSP, 105 ± 17 mm2 for DLB, 130 ± 26 mm2 for PD and 135 ± 23 mm2 for CTRL. The mean segmented volumes of the midbrain were 5595 ± 680 mm3 for PSP, 6051 ± 566 mm3 for DLB, 6646 ± 802 mm3 for PD and 6882 ± 844 mm3 for CTRL. The calculated midbrain pons ratios did not show superiority over the absolute measurements of the midbrain for distinguishing PSP from DLB. Because of the relatively uniform atrophy throughout the brainstem, the ratios were not suitable for distinguishing DLB from PD. Conclusions DLB patients exhibit homogenous atrophy of the brainstem and can be distinguished from patients with PSP and PD by both manual measurement methods and automated volume segmentation using absolute values or ratios.https://doi.org/10.1186/s12883-023-03151-4Dementia with Lewy BodiesMRIAtrophyBrainstem
spellingShingle Sebastian Johannes Müller
Eya Khadhraoui
Niels Hansen
Ala Jamous
Philip Langer
Jens Wiltfang
Christian Heiner Riedel
Caroline Bouter
Christoph van Riesen
Fabian Maass
Michael Bartl
Claudia Lange
Marielle Ernst
Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
BMC Neurology
Dementia with Lewy Bodies
MRI
Atrophy
Brainstem
title Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
title_full Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
title_fullStr Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
title_full_unstemmed Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
title_short Brainstem atrophy in dementia with Lewy bodies compared with progressive supranuclear palsy and Parkinson’s disease on MRI
title_sort brainstem atrophy in dementia with lewy bodies compared with progressive supranuclear palsy and parkinson s disease on mri
topic Dementia with Lewy Bodies
MRI
Atrophy
Brainstem
url https://doi.org/10.1186/s12883-023-03151-4
work_keys_str_mv AT sebastianjohannesmuller brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT eyakhadhraoui brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT nielshansen brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT alajamous brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT philiplanger brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT jenswiltfang brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT christianheinerriedel brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT carolinebouter brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT christophvanriesen brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT fabianmaass brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT michaelbartl brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT claudialange brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri
AT marielleernst brainstematrophyindementiawithlewybodiescomparedwithprogressivesupranuclearpalsyandparkinsonsdiseaseonmri